MY ACCOUNT | NEWSLETTER |

Luna, Bella, Charlie among top pet names for 2022: Embrace Pet Insurance

Most common insurance claims for dogs and cats include vomiting, diarrhea, UTI


Embrace Pet Insurance recently shared the most popular pet names, breeds and common insurance claims from 2022. The list is based on insights from a database of over 1.5 million quotes, according to a news release

The top ten dog names of 2022 were Luna, Bella, Charlie, Lucy, Daisey, Cooper, Max, Bailey, Milo and Coco. On the feline side, the top names in 2022 include Luna, Oliver, Milo, Bella, Charlie, Leo, Loki, Lucy, Nala and Lilly. 

The most popular dog breeds of 2022 in order were mixed breeds, Labrador Retriever, Golden Retriever, Goldendoodle, German Shepard, French Bulldog, Yorkshire Terrier, Siberian Husky, Labradoodle and Chihuahua. Top cat breeds include mixed breeds, Tabby, Maine Coon, Siamese, Ragdoll, Bengal, Siberian, Sphynx, Persian and Russian Blue. 

According to the company, the most common insurance claims for dogs and cats in 2022 were vomiting, diarrhea, urinary tract infection, weight loss and otitis externa or ear infection. 

In the news release, Brian Macias, president of Embrace Pet Insurance said the company has witnessed the pet insurance industry consistently grow and that 2022 was not an exception. 

"When unexpected accidents and illnesses happen, a pet parent's focus should be on helping their pet get well, not worrying about the impact of medical expenses,” he said. “That's why we're seeing so many more pet owners begin to understand the incredible value of pet insurance – it's peace of mind your pet is protected when they need it most."

For more information about Embrace Pet Insurance, please visit embracepetinsurance.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

WVAC 2024 - April 16-19, Cape Town

Like1
Dislike0

Interview With Dr. Anthony Pease

Like0
Dislike0

Human exposures to Brucella canis from a pregnant dog during an international flight: Public health risks, diagnostic challenges, and future considerations

Like0
Dislike0

Efficacy of antimicrobial and nutraceutical treatment for canine acute diarrhoea

Like0
Dislike0

Evaluation of the clinical efficacy of racecadotril in the treatment of neonatal calves with infectious diarrhea.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top